Osteoblast-derived WNT16 represses osteoclastogenesis and prevents cortical bone fragility fractures
Nature Medicine2014Vol. 20(11), pp. 1279–1288
Citations Over TimeTop 1% of 2014 papers
Sofia Movérare‐Skrtic, Petra Henning, Xianwen Liu, Kenichi Nagano, Hiroaki Saito, Anna Börjesson, Klara Sjögren, Sara H. Windahl, Helen Farman, Bert Kindlund, Cecilia Engdahl, Antti Koskela, Fuping Zhang, Emma E Eriksson, Farasat Zaman, Ann Hammarstedt, Hanna Isaksson, Marta Bally, Ali Kassem, Catharina Lindholm, Olof Sandberg, Per Aspenberg, Lars Sävendahl, Jian Q. Feng, Jan Tuckermann, Juha Tuukkanen, Matti Poutanen, Roland Baron, Ulf H. Lerner, Francesca Gori, Claes Ohlsson
Related Papers
- → Aging effect of osteoprotegerin and receptor activator of nuclear factor-κB ligand expression in human periodontal ligament cells under continuous static pressure.(2022)3 cited
- [Indication of osteoprotegerin (OPG) and receptor activator of nuclear factor kappa B ligand (RANKL) in gingival crevicular fluid to remodeling of alveolar bone during retention].(2012)
- [Expressions of RANK, RANKL, and osteoprotegerin in male rats at different ages].(2011)
- Different expressing levels of osteoprotegerin and receptor activator of nuclear factor-κB ligand from osteoblasts of young, adult and aged mice(2005)
- EFFECTS OF 1α,25(OH)_2D_3 ON THE EXPRESSION OF RECEPTOR ACTIVATOR OF NF-КB LIGAND AND OSTEOPROTEGERIN IN RAT OSTEOBLASTS IN VITRO(2010)